by TractManager | Aug 31, 2011 | Emerging Technology Report
An oral kinase inhibitor for the treatment of non-small-cell lung cancer for patients with an abnormal ALK gene. If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Aug 23, 2011 | Emerging Technology Report
An intravenous agent for second-line treatment of systemic ALCL.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Aug 23, 2011 | Emerging Technology Report
An intravenous agent for the treatment of patients with refractory or relapsed Hodgkin lymphoma.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Aug 17, 2011 | Emerging Technology Report
A monoclonal antibody for the treatment of relapsing remitting multiple sclerosis.If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Aug 9, 2011 | Emerging Technology Report
An oral factor Xa inhibitor for the prevention of VTE following hipe or knee surgery. If you have a Hayes login, click here to view the full report on the Knowledge Center.
Recent Comments